Synapse Open Synapse
Biology

Iambic, an AI drug discovery specialist, banks $150M in an IPO

BioPharma Dive · · 2 min read

Part of a wave of young biotechs employing AI to accelerate research, the company claimed in regulatory filings that its approach has the potential to “disrupt legacy drug discovery paradigms.”

Latest from BioPharma Dive